Acetylsalicylic acid/dipyridamole

Aspirin and dipyridamole

Acetylsalicylic Acid/Dipyridamole is a combination drug therapy used in the prevention of stroke and is particularly indicated for patients who have experienced a transient ischemic attack (TIA) or a previous stroke due to thrombosis. Acetylsalicylic acid, commonly known as aspirin, acts as an antiplatelet agent, inhibiting the formation of blood clots. Dipyridamole works by a different mechanism, causing vasodilation and also having antiplatelet effects, thereby synergistically enhancing the antithrombotic action of aspirin.

Indications

This combination is specifically indicated for the secondary prevention of stroke and is often prescribed to individuals who have had a TIA or a stroke in the past. Its use is based on the principle that the dual antiplatelet therapy is more effective in reducing the risk of future stroke than either agent alone.

Mechanism of Action

Acetylsalicylic Acid (ASA) exerts its effect by irreversibly inhibiting the enzyme cyclooxygenase (COX), which is essential in the synthesis of thromboxane A2, a molecule that promotes platelet aggregation and vasoconstriction. Dipyridamole enhances the levels of adenosine by inhibiting its uptake into platelets, endothelial cells, and erythrocytes, which leads to increased cyclic adenosine monophosphate (cAMP) within platelets and the formation of the potent vasodilators adenosine and prostacyclin. The increase in cAMP levels inhibits platelet aggregation. The combination of these mechanisms provides a broad spectrum of antiplatelet activity.

Dosage and Administration

The dosage of acetylsalicylic acid/dipyridamole is typically one capsule twice a day, once in the morning and once in the evening. It is important to follow the prescribing information closely and consult with a healthcare provider for any adjustments or concerns regarding the treatment regimen.

Side Effects

Common side effects include headache, dizziness, and gastrointestinal issues such as nausea and abdominal pain. Due to its antiplatelet properties, there is an increased risk of bleeding. Patients should be monitored for signs of bleeding and advised to report any unusual bleeding or bruising.

Contraindications

This medication is contraindicated in patients with hypersensitivity to either acetylsalicylic acid, dipyridamole, or any component of the product. It should also be used with caution in patients with a history of peptic ulcer disease or those who are at increased risk of bleeding due to other medical conditions or concurrent drug therapy.

Drug Interactions

Acetylsalicylic acid/dipyridamole may interact with other medications, including anticoagulants, other antiplatelet agents, and nonsteroidal anti-inflammatory drugs (NSAIDs), increasing the risk of bleeding. It is important to inform the healthcare provider of all medications being taken to avoid potential drug interactions.

Conclusion

The acetylsalicylic acid/dipyridamole combination is an effective therapy for the secondary prevention of stroke, offering a dual mechanism of action that targets different pathways in the clot formation process. While it is generally well-tolerated, patients should be aware of the potential side effects and interactions with other medications.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian